TickerFactsScreenerDevelopers

Denali Therapeutics Inc. (DNLI) — Operating Income

Annual figures by fiscal year, from SEC filings.

2016: -$87.43M2017: -$90.14M2018: -$46.37M2019: -$213.18M2020: $62.72M2021: -$295.75M2022: -$340.74M2023: -$196.70M2024: -$487.34M2025: -$555.34M-$555.34M
2016Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$555.34M-14.0%
2024-$487.34M-147.8%
2023-$196.70M+42.3%
2022-$340.74M-15.2%
2021-$295.75M-571.6%
2020$62.72M+129.4%
2019-$213.18M-359.7%
2018-$46.37M+48.6%
2017-$90.14M-3.1%
2016-$87.43M—